Literature DB >> 25626998

Type III collagen modulates fracture callus bone formation and early remodeling.

Emily L Miedel1, Becky K Brisson, Todd Hamilton, Hadley Gleason, Gary P Swain, Luke Lopas, Derek Dopkin, Joseph E Perosky, Kenneth M Kozloff, Kurt D Hankenson, Susan W Volk.   

Abstract

Type III collagen (Col3) has been proposed to play a key role in tissue repair based upon its temporospatial expression during the healing process of many tissues, including bone. Given our previous finding that Col3 regulates the quality of cutaneous repair, as well as our recent data supporting its role in regulating osteoblast differentiation and trabecular bone quantity, we hypothesized that mice with diminished Col3 expression would exhibit altered long-bone fracture healing. To determine the role of Col3 in bone repair, young adult wild-type (Col3+/+) and haploinsufficent (Col3+/-) mice underwent bilateral tibial fractures. Healing was assessed 7, 14, 21, and 28 days following fracture utilizing microcomputed tomography (microCT), immunohistochemistry, and histomorphometry. MicroCT analysis revealed a small but significant increase in bone volume fraction in Col3+/- mice at day 21. However, histological analysis revealed that Col3+/- mice have less bone within the callus at days 21 and 28, which is consistent with the established role for Col3 in osteogenesis. Finally, a reduction in fracture callus osteoclastic activity in Col3+/- mice suggests Col3 also modulates callus remodeling. Although Col3 haploinsufficiency affected biological aspects of bone repair, it did not affect the regain of mechanical function in the young mice that were evaluated in this study. These findings provide evidence for a modulatory role for Col3 in fracture repair and support further investigations into its role in impaired bone healing.
© 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  extracellular matrix; fracture; type III collagen

Mesh:

Substances:

Year:  2015        PMID: 25626998      PMCID: PMC4406871          DOI: 10.1002/jor.22838

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  39 in total

1.  Oral health in prevalent types of Ehlers-Danlos syndromes.

Authors:  Peter J De Coster; Luc C Martens; Anne De Paepe
Journal:  J Oral Pathol Med       Date:  2005-05       Impact factor: 4.253

2.  Optimizing collagen antigen unmasking in paraffin-embedded tissues.

Authors:  K Wakamatsu; M Ghazizadeh; M Ishizaki; Y Fukuda; N Yamanaka
Journal:  Histochem J       Date:  1997-01

3.  Effects of rehydration state on the flexural properties of whole mouse long bones.

Authors:  J J Broz; S J Simske; A R Greenberg; M W Luttges
Journal:  J Biomech Eng       Date:  1993-11       Impact factor: 2.097

4.  Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development.

Authors:  X Liu; H Wu; M Byrne; S Krane; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Authors:  T Kon; T J Cho; T Aizawa; M Yamazaki; N Nooh; D Graves; L C Gerstenfeld; T A Einhorn
Journal:  J Bone Miner Res       Date:  2001-06       Impact factor: 6.741

6.  Mature osteoblasts in human non-union fractures express collagen type III.

Authors:  D M Lawton; J G Andrew; D R Marsh; J A Hoyland; A J Freemont
Journal:  Mol Pathol       Date:  1997-08

7.  Influence of aging on biological properties of periodontal ligament cells.

Authors:  Bruno Braga Benatti; Karina Gonzales Silvério; Marcio Zaffalon Casati; Enilson Antônio Sallum; Francisco Humberto Nociti
Journal:  Connect Tissue Res       Date:  2008       Impact factor: 3.417

8.  Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta.

Authors:  J A Meganck; D L Begun; J D McElderry; A Swick; K M Kozloff; S A Goldstein; M D Morris; J C Marini; M S Caird
Journal:  Bone       Date:  2013-06-14       Impact factor: 4.398

9.  Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.

Authors:  Xiao-Dong Chen; Vladimir Dusevich; Jian Q Feng; Stavros C Manolagas; Robert L Jilka
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

10.  Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway.

Authors:  M Tang; M Zhong; Y Shang; H Lin; J Deng; H Jiang; H Lu; Y Zhang; W Zhang
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

View more
  8 in total

1.  Perlecan Knockdown Significantly Alters Extracellular Matrix Composition and Organization During Cartilage Development.

Authors:  Alexander R Ocken; Madeline M Ku; Tamara L Kinzer-Ursem; Sarah Calve
Journal:  Mol Cell Proteomics       Date:  2020-05-07       Impact factor: 5.911

Review 2.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

3.  Type III collagen is a key regulator of the collagen fibrillar structure and biomechanics of articular cartilage and meniscus.

Authors:  Chao Wang; Becky K Brisson; Masahiko Terajima; Qing Li; Kevt'her Hoxha; Biao Han; Abby M Goldberg; X Sherry Liu; Michele S Marcolongo; Motomi Enomoto-Iwamoto; Mitsuo Yamauchi; Susan W Volk; Lin Han
Journal:  Matrix Biol       Date:  2019-10-23       Impact factor: 11.583

4.  Aberrant structure of fibrillar collagen and elevated levels of advanced glycation end products typify delayed fracture healing in the diet-induced obesity mouse model.

Authors:  Deepak Kumar Khajuria; Marwa Soliman; John C Elfar; Gregory S Lewis; Thomas Abraham; Fadia Kamal; Reyad A Elbarbary
Journal:  Bone       Date:  2020-05-18       Impact factor: 4.398

5.  Cysteine-rich domain of type III collagen N-propeptide inhibits fibroblast activation by attenuating TGFβ signaling.

Authors:  Becky K Brisson; Daniel C Stewart; Chelsea Burgwin; David Chenoweth; Rebecca G Wells; Sherrill L Adams; Susan W Volk
Journal:  Matrix Biol       Date:  2022-03-24       Impact factor: 10.447

6.  Development of a novel murine delayed secondary fracture healing in vivo model using periosteal cauterization.

Authors:  Ina Gröngröft; Sandra Wissing; Dennis M Meesters; Martijn Poeze; Romano Matthys-Mark; Keita Ito; Stephan Zeiter
Journal:  Arch Orthop Trauma Surg       Date:  2019-08-09       Impact factor: 3.067

Review 7.  Animal Models of Ehlers-Danlos Syndromes: Phenotype, Pathogenesis, and Translational Potential.

Authors:  Robin Vroman; Anne-Marie Malfait; Rachel E Miller; Fransiska Malfait; Delfien Syx
Journal:  Front Genet       Date:  2021-10-12       Impact factor: 4.599

8.  Spheroid co-culture of BMSCs with osteocytes yields ring-shaped bone-like tissue that enhances alveolar bone regeneration.

Authors:  Ying-Hui Zhou; Yue Guo; Jia-Yu Zhu; Chen-Yi Tang; Ya-Qiong Zhao; Hou-De Zhou
Journal:  Sci Rep       Date:  2022-08-27       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.